http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109620967-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9add8f0d3e428b7654b0541d170c3e08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6903
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
filingDate 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d473da0914e66c64584b4c187e32d5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4019b5d456b8918fb99f5133c8f8c3b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5849af8d2ddcd72a012bf1a10355507d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a740ad6c29d4d95b6d61173d870de72a
publicationDate 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109620967-A
titleOfInvention A targeted doxorubicin-loaded supramolecular hydrogel and preparation method thereof
abstract The invention provides a targeted doxorubicin-loaded supramolecular hydrogel, which is characterized in that it is composed of α-cyclodextrin, Pluronic F127, DOX-2N-β-CD and FA-2N-β-CD The reaction is obtained. The method for preparing the targeted doxorubicin-loaded supramolecular hydrogel is characterized in that, comprising the steps of: weighing DOX-2N-β-CD, Pluronic F127 and FA-2N-β-CD in In the reactor, deionized water is added, and the reaction is stirred; α-CD is added, and the reaction is continued to be stirred. After the reaction is completed, the reaction system is allowed to stand for 10-15 h to obtain a targeted adriamycin-loaded supramolecular hydrogel. In the present invention, the drug molecules folic acid and doxorubicin are respectively loaded in the hydrogel network in the form of covalent bonds, which can not only reduce the toxic and side effects of the drug doxorubicin, but also effectively improve the targeting property of the hydrogel.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114344247-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111728939-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111728939-B
priorityDate 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424388872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431749912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414927286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408050614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14398587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798

Total number of triples: 59.